Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation
J. Clin. Invest. Karen M. Dwyer, et al. 113:1440 doi:10.1172/JCI19560 [Go to this article.]

Table 1
Survival of αGal_positive to αGal^_/_ cardiac allografts (days) following injection of 0.075 mg anti-αGal IgG1 mAb